QHSLab, Inc. (OTCMKTS:USAQ – Get Rating) – Equities researchers at Litchfield Hills Research issued their Q2 2023 earnings estimates for shares of QHSLab in a report issued on Friday, December 2nd. Litchfield Hills Research analyst T. O�Neill forecasts that the company will earn ($0.01) per share for the quarter. The consensus estimate for QHSLab's current full-year earnings is ($0.08) per share. Litchfield Hills Research also issued estimates for QHSLab's Q3 2023 earnings at ($0.01) EPS and Q4 2023 earnings at $0.00 EPS.

QHSLab Price Performance

QHSLab stock opened at $0.15 on Monday. QHSLab has a 52-week low of $0.12 and a 52-week high of $0.75. The company has a current ratio of 0.27, a quick ratio of 0.21 and a debt-to-equity ratio of 0.73. The company's 50 day moving average is $0.16 and its two-hundred day moving average is $0.24.

QHSLab Company Profile

QHSLab, Inc, a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine.

Read More

• Get a free copy of the StockNews.com research report on QHSLab (USAQ)
• Could Pinduoduo Be the Best Chinese Stock to Own?
• 3 Consumer Cyclical Stocks With Good Momentum
• 3 Big Box Retail Bets for the Holidays
• How Long Does it Take to Become a Profitable Trader?
• Is Autozone Ready To Rally For Another Profitable Lap?

Receive News & Ratings for QHSLab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QHSLab and related companies with MarketBeat.com's FREE daily email newsletter.